LISBON, Portugal – July 2014:In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance (NPS), 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR). The two organizations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 4,4′-DMAR as stipulated by Article 5.1 of the Council Decision. With this Joint Report, the EMCDDA and Europol published new available information on 4-4’-DMAR in terms of its analogy with better-studied compounds; new evidence of the potential for further (rapid) spread; and new evidence of cases of serious intoxication or fatalities. In detail, the organizations reported of first indications of the risks associated with the new psychoactive substance, including the health and social risks, and of the characteristics of users under Article 5.2(d) of the Council Decision.

For further information please see:
http://www.emcdda.europa.eu/publications/joint-reports/4-4-DMAR